Capra Biosciences

Capra Biosciences is developing a new technology that will make the manufacturing of chemicals using biology cost-competitive with petroleum-based products. Significant advances in synthetic biology have been made over the past 20 years, enabling a multitude of products with lower environmental impact and potentially better performance than their petrochemical counterparts. However, cost-competitive large-scale manufacturing of these products remains a significant bottleneck to their adaptation. Our technology tackles this bottleneck through an innovative bioreactor design that promises to significantly reduce end-to-end manufacturing costs

Synthetic biology,biosynthesis,and chemical manufacturing

Capra biosciences operates in the Biotechnology research industry.

Capra biosciences's revenue is 1m - 10m

Capra biosciences has 11 - 50 employees.